本次公司以债转股的方式对子公司进行增资，是为缓解江苏百奥的资金压力，优化其内部资源配置及资 产负债结构，提高子公司综合竞争力，促进公司及子公司整体的良性运营和可持续发展。本次增资符合 公司的长远发展目标和股东的利益，不会对公司的正常经营产生不利影响。 本次增资实施前，江苏百奥的注册资本为1111.1111万元人民币，百奥赛图持有江苏百奥100%的股权;本 次增资实施后，江苏百奥的注册资本将增加至1.76亿元，公司仍持有江苏百奥100%的股权。 百奥赛图-B(02315)发布公告，为缓解江苏百奥的资金压力，优化其内部资源配置及资产负债结构，百 奥赛图拟以对江苏百奥5.5亿元的债权以债转股的方式，转为对江苏百奥的增资款，其中1.65亿元计入注 册资本，3.85亿元计入资本公积。相关债权不存在抵押、质押，亦不存在涉及有关债权的重大争议、诉 讼或仲裁事项、查封或者冻结等司法措施。 ...

本次公司以债转股的方式对子公司进行增资，是为缓解江苏百奥的资金压力，优化其内部资源配置及资 产负债结构，提高子公司综合竞争力，促进公司及子公司整体的良性运营和可持续发展。本次增资符合 公司的长远发展目标和股东的利益，不会对公司的正常经营产生不利影响。 智通财经APP讯，百奥赛图-B(02315)发布公告，为缓解江苏百奥的资金压力，优化其内部资源配置及资 产负债结构，百奥赛图拟以对江苏百奥5.5亿元的债权以债转股的方式，转为对江苏百奥的增资款，其 中1.65亿元计入注册资本，3.85亿元计入资本公积。相关债权不存在抵押、质押，亦不存在涉及有关债 权的重大争议、诉讼或仲裁事项、查封或者冻结等司法措施。 本次增资实施前，江苏百奥的注册资本为1111.1111万元人民币，百奥赛图持有江苏百奥100%的股权;本 次增资实施后，江苏百奥的注册资本将增加至1.76亿元，公司仍持有江苏百奥100%的股权。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688796 证券简称：百奥赛图 公告编号：2026-007 百奥赛图（北京）医药科技股份有限公司 关于使用闲置自有资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 基本情况 ■ ● 已履行及拟履行的审议程序 百奥赛图（北京）医药科技股份有限公司（以下简称"公司"）于2026年1月27日召开第二届董事会审计 委员会2026年第一次会议、第二届董事会第十五次会议，审议通过了《关于使用闲置自有资金进行现金 管理的议案》，本事项无需提交股东会审议。 ● 特别风险提示 本次现金管理用于购买安全性高、流动性好、风险较低的银行及其他金融机构发行的理财产品，总体风 险可控。但金融市场受宏观经济的影响较大，公司将根据经济形势以及金融市场的变化适时适量的介 入，但不排除该项投资受到市场波动的影响。 一、投资情况概述 （一）投资目的 为提高公司自有资金使用效率，在确保不影响公司正常生产经营以及确保资金安全的前提下，公司拟合 理利用部分闲置自有资金 ...

Core Viewpoint - The company has approved a capital increase for its subsidiary, Cangzhou Aodesai Chemical Co., Ltd., through a debt-to-equity swap to improve its capital structure [1] Group 1: Capital Increase Details - The company’s subsidiary, Beijing Aodesai Chemical Co., Ltd., will convert its debt of 130 million yuan into equity for Cangzhou Aodesai, increasing its registered capital from 20 million yuan to 150 million yuan [1] - Cangzhou Aodesai remains a wholly-owned subsidiary of the company after the capital increase [1] Group 2: Business Registration Changes - Cangzhou Aodesai has completed the necessary business registration changes and obtained a new business license from the Cangzhou Lingang Economic and Technological Development Zone Administrative Approval Bureau [1] - The updated business license reflects a registered capital of 150 million yuan, while other registration details remain unchanged [1] Group 3: Company Information - Cangzhou Aodesai Chemical Co., Ltd. was established on December 9, 2015, and is located in Cangzhou, Hebei Province [1] - The company operates in the manufacturing and sales of specialized chemical products and basic chemical raw materials, among other activities [1]

Group 1 - The company plans to conduct financial derivative transactions in 2026 to effectively hedge against exchange rate risks, with a maximum contract value of RMB 400 million and a maximum margin and premium of RMB 40 million [6][10] - The board of directors approved the proposal for the financial derivative trading limit on December 30, 2025, and it does not require shareholder approval [2][10] - The company will use its own or self-raised funds for these transactions and will not use raised funds directly or indirectly [8] Group 2 - The financial derivative trading aims to mitigate the adverse effects of exchange rate fluctuations on the company's international operations, ensuring financial safety and core business profitability [4][14] - The company will adhere to principles such as maintaining exchange rate risk neutrality and basing hedging on actual business needs [5] - The trading will include instruments like foreign exchange forwards, swaps, and interest rate swaps, conducted only with qualified financial institutions [8] Group 3 - The company has established a risk control framework for derivative trading, including clear objectives, internal control systems, and careful selection of trading partners [12][11] - The company will monitor market factors related to the contracts and report regularly to management [13] - The board has authorized management to implement the derivative trading within the approved limits and duration [10] Group 4 - The company is also planning to apply for a comprehensive credit limit of up to RMB 7.5 billion and EUR 80 million for 2026 to support its operational goals [39] - The credit will be used for various financing needs, including short-term loans and bank guarantees, and will be available for use within the specified period [39][40] - The board has authorized management to sign relevant legal documents within the approved credit limits [40] Group 5 - The company is focusing on enhancing its core automotive parts business, particularly in the electric vehicle sector, with significant revenue growth from related components [31] - The company emphasizes investor communication and transparency, ensuring timely disclosure of important information and engaging with investors through various channels [32][33] - The company is committed to improving corporate governance and compliance, having revised its governance documents and established new management systems [34][35]

Core Viewpoint - The company plans to increase its investment in its wholly-owned subsidiary, Hengyue Security, by 100 million yuan through a debt-to-equity conversion, which will be fully allocated to capital reserves. This move aims to optimize the subsidiary's capital structure and aligns with the company's overall strategy [1] Group 1 - The board meeting is scheduled for December 12, 2025, to review the proposal for the capital increase [1] - After the capital increase, Hengyue Security's registered capital will remain at 300 million yuan, with the company retaining 100% ownership [1] - The capital increase is subject to approval by the shareholders' meeting [1] Group 2 - Hengyue Security reported a revenue of 109 million yuan and a net loss of 15.04 million yuan for the year 2024 [1] - For the period from January to September 2025, Hengyue Security achieved a revenue of 201 million yuan and a net profit of 3.35 million yuan [1] - The capital increase is expected to improve Hengyue Security's asset-liability structure [1]

Group 1 - Meilixin plans to raise no more than 1.2 billion yuan for semiconductor equipment precision components, communication and automotive parts projects, and to supplement working capital [2] - Olin Bio has prepaid corporate income tax totaling 4.2001 million yuan, with no penalties from tax authorities [3] - Haisen Pharmaceutical's directors and executives plan to reduce their holdings by no more than 124,300 shares, accounting for 0.0816% of the total share capital [4] Group 2 - Aibulu intends to sell 47.4% and 31.6% stakes in its subsidiary Jinque Agriculture for a total of 12.3914 million yuan [5] - Chaoying Electronics plans to increase its Thai subsidiary's capital by 100 million USD for AI high-end PCB expansion [6] - Bona Film Group states that the box office revenue for "Avatar 3" is difficult to predict and the investment return rights are low [7] Group 3 - Junya Technology's PCB products for humanoid robots contribute less than 0.05% to its revenue [9] - Aerospace Electromechanical confirms that its main business does not involve commercial aerospace [10] - Deyi Culture's major shareholder plans to reduce holdings by no more than 2% of shares [11] Group 4 - China National Materials International signed a 2.7 billion yuan engineering contract for a molybdenum mining project [12] - Weiguang Bio plans to sign a 1.13 billion yuan technology cooperation contract for blood products [13] - Suhao Huihong intends to swap assets with its controlling shareholder for a 2.33% stake in Zijin Property Insurance [14] Group 5 - Haike Xinyuan's employee strategic placement plan intends to reduce holdings by no more than 2.5% of shares [15][16] - Taihao Technology's vice president resigns for personal reasons [17] - Huazhu Gaoke plans to establish a joint venture for 3D printing services with a total investment of 100 million yuan [18] Group 6 - Hubei Energy's November power generation was 2.617 billion kWh, a decrease of 17.94% year-on-year [19] - Dong'a Ejiao plans to repurchase shares worth 100 million to 200 million yuan for capital reduction [20] - Longjiang Transportation's shareholder reduced holdings by 1.2% [21] Group 7 - Feilu Co. plans to reduce holdings by no more than 1.02% of shares [22] - Zhongwei Electronics is planning a change in control, leading to a temporary stock suspension [23] - Zhongheng Group's subsidiary received approval for clinical trials of a new cancer drug [24] Group 8 - Guanzhong Ecology's controlling shareholder changed to Deep Blue Financial Whale [25] - Shennong Seed Industry is transferring a 3.8% stake in a subsidiary for 31.9827 million yuan [26] - Sun Cable's major shareholder plans to reduce holdings by no more than 3% of shares [27] Group 9 - Aiwei Electronics' application for issuing convertible bonds has been approved by the Shanghai Stock Exchange [28] - Chongqing Water intends to acquire wastewater treatment projects for 255 million yuan [29] - Boyun New Materials plans to increase its subsidiary's capital by 285 million yuan through debt-to-equity conversion [30] Group 10 - Zhongbai Group is closing unprofitable stores, expecting a loss of approximately 180 million yuan [31] - Changyuan Power's November power generation decreased by 17.88% year-on-year [32]

Group 1 - The company will hold its third extraordinary general meeting of shareholders on December 22, 2025, to discuss various proposals [1][4][36] - The meeting will combine on-site voting and online voting, with specific time slots for each [1][7] - Shareholders must register by December 17, 2025, to attend the meeting [1][5] Group 2 - The company plans to increase capital for its subsidiary, Changsha Xinhang Brake Co., Ltd., through a debt-to-equity swap amounting to RMB 284.5866 million [15][19] - This capital increase aims to optimize the subsidiary's capital structure and enhance its operational capabilities [22] - The debt-to-equity swap will not constitute a related party transaction or a major asset restructuring [16] Group 3 - The company has proposed amendments to its articles of association, including renaming the "Audit and Compliance Management Committee" to "Audit Committee" [25][26] - The amendments require approval from shareholders at the upcoming meeting [26][36] - The company will also revise certain management systems to align with the new committee name [27][28] Group 4 - The company announced the resignation of independent director Mr. Xiao Jiayu due to personal health reasons [29] - His resignation will temporarily reduce the number of independent directors below the required threshold [29] - The company will expedite the process to elect a new independent director to maintain board functionality [29] Group 5 - The company’s board of directors has decided to delay the board re-election to ensure continuity and stability in operations [31] - The current board members will continue to fulfill their duties until the new board is elected [31]

Group 1 - The core point of the announcement is that the company has approved a capital increase for its subsidiary, Gu Hai Hot Spring Co., Ltd., through a debt-to-equity swap, converting 90 million RMB of debt into equity, increasing the subsidiary's registered capital from 10 million RMB to 100 million RMB, and raising the company's ownership stake from 92.50% to 99.25% [2][8][19] Group 2 - The board meeting was held on December 1, 2025, with all 9 directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][4] - The debt-to-equity swap aims to optimize the asset-liability structure of Gu Hai Hot Spring Co., Ltd. and enhance its liquidity and attractiveness [2][8] - The capital increase does not involve related party transactions and does not constitute a major asset restructuring as defined by regulations [9][19] - The company will continue to consolidate Gu Hai Hot Spring Co., Ltd. in its financial statements, and the overall financial and operational status of the company will not be adversely affected [20]

Core Viewpoint - The company has approved a capital increase for its wholly-owned subsidiary, Wuhu Jusa Long New Materials Technology Co., Ltd., through a debt-to-equity conversion of 170 million RMB, aimed at optimizing internal resource allocation and improving its asset-liability structure [1]. Group 1 - The board of directors has passed a resolution regarding the capital increase via debt-to-equity conversion [1]. - The capital increase amounts to 170 million RMB [1]. - The decision is based on the company's operational management needs [1].